Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma | 75 | 2016 | 1877 | 2.890 |
Why?
|
Lymphoma, B-Cell | 55 | 2017 | 931 | 2.890 |
Why?
|
Hodgkin Disease | 47 | 2016 | 1415 | 2.290 |
Why?
|
Lymphoma, Non-Hodgkin | 50 | 2014 | 1381 | 2.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 36 | 2023 | 1378 | 1.970 |
Why?
|
Lymphoma, Follicular | 21 | 2016 | 435 | 1.600 |
Why?
|
Immunophenotyping | 58 | 2016 | 1880 | 1.390 |
Why?
|
Herpesvirus 4, Human | 30 | 2023 | 1041 | 1.070 |
Why?
|
Mediastinal Neoplasms | 12 | 2016 | 423 | 0.900 |
Why?
|
Lymphoma, T-Cell | 20 | 2014 | 299 | 0.890 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 15 | 2014 | 180 | 0.850 |
Why?
|
Lymphoproliferative Disorders | 15 | 2018 | 524 | 0.840 |
Why?
|
Epstein-Barr Virus Infections | 11 | 2023 | 570 | 0.800 |
Why?
|
Burkitt Lymphoma | 10 | 2023 | 327 | 0.760 |
Why?
|
Diagnosis, Differential | 58 | 2018 | 12961 | 0.750 |
Why?
|
Leukemia | 13 | 2011 | 1510 | 0.740 |
Why?
|
Splenic Neoplasms | 7 | 2006 | 100 | 0.730 |
Why?
|
World Health Organization | 21 | 2016 | 1318 | 0.720 |
Why?
|
Lymph Nodes | 30 | 2014 | 3476 | 0.690 |
Why?
|
Lymphomatoid Papulosis | 3 | 2015 | 16 | 0.680 |
Why?
|
Lymphoma, T-Cell, Peripheral | 8 | 2014 | 134 | 0.660 |
Why?
|
Thymoma | 7 | 2015 | 186 | 0.660 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 4 | 2015 | 169 | 0.640 |
Why?
|
Thymus Neoplasms | 6 | 2015 | 268 | 0.600 |
Why?
|
Immunohistochemistry | 55 | 2018 | 11366 | 0.590 |
Why?
|
Herpesviridae Infections | 4 | 2014 | 277 | 0.560 |
Why?
|
Lymphoid Tissue | 10 | 2001 | 455 | 0.560 |
Why?
|
T-Lymphocytes | 25 | 2018 | 10183 | 0.550 |
Why?
|
Germinal Center | 7 | 2017 | 377 | 0.530 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 18 | 2017 | 1596 | 0.530 |
Why?
|
Orbital Neoplasms | 8 | 2007 | 225 | 0.530 |
Why?
|
Lymphocytes | 16 | 2016 | 2617 | 0.520 |
Why?
|
Nematode Infections | 1 | 2014 | 22 | 0.500 |
Why?
|
Immunoenzyme Techniques | 24 | 2007 | 1799 | 0.490 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 1 | 2014 | 23 | 0.480 |
Why?
|
Helminthiasis | 1 | 2014 | 66 | 0.470 |
Why?
|
Lymphatic Diseases | 6 | 2016 | 323 | 0.460 |
Why?
|
Cyclins | 7 | 1997 | 603 | 0.440 |
Why?
|
Gene Rearrangement | 10 | 2015 | 1179 | 0.430 |
Why?
|
Plasma Cells | 9 | 2010 | 591 | 0.430 |
Why?
|
Hematologic Neoplasms | 9 | 2009 | 1832 | 0.410 |
Why?
|
Neoplasms, Multiple Primary | 6 | 2006 | 604 | 0.410 |
Why?
|
Leukemia, Lymphoid | 6 | 2016 | 315 | 0.400 |
Why?
|
Microscopy | 2 | 2014 | 902 | 0.400 |
Why?
|
Immunity, Mucosal | 1 | 2014 | 490 | 0.380 |
Why?
|
Vaccinia virus | 5 | 1995 | 349 | 0.380 |
Why?
|
B-Lymphocytes | 21 | 2006 | 4666 | 0.370 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 2 | 2004 | 20 | 0.370 |
Why?
|
Oncogene Proteins | 6 | 1997 | 749 | 0.360 |
Why?
|
Conjunctival Neoplasms | 2 | 2007 | 79 | 0.360 |
Why?
|
Humans | 304 | 2023 | 744366 | 0.350 |
Why?
|
Intestinal Diseases | 1 | 2014 | 530 | 0.350 |
Why?
|
Cyclin D1 | 8 | 2012 | 463 | 0.340 |
Why?
|
Skin Neoplasms | 14 | 2015 | 5692 | 0.330 |
Why?
|
Herpesvirus 8, Human | 6 | 2014 | 258 | 0.320 |
Why?
|
Sialadenitis | 4 | 2010 | 43 | 0.310 |
Why?
|
Antigens, CD | 16 | 2012 | 4026 | 0.310 |
Why?
|
Eye Neoplasms | 2 | 2007 | 312 | 0.300 |
Why?
|
Immunoblastic Lymphadenopathy | 3 | 2013 | 35 | 0.290 |
Why?
|
Neprilysin | 6 | 2005 | 439 | 0.290 |
Why?
|
Antigens, Neoplasm | 10 | 2003 | 1988 | 0.290 |
Why?
|
Reed-Sternberg Cells | 5 | 2012 | 73 | 0.290 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 7 | 2006 | 111 | 0.290 |
Why?
|
Killer Cells, Natural | 6 | 2014 | 2133 | 0.280 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2007 | 65 | 0.280 |
Why?
|
Bone Neoplasms | 5 | 2017 | 2530 | 0.270 |
Why?
|
Bone Marrow | 8 | 2004 | 2948 | 0.270 |
Why?
|
Lymphoma, AIDS-Related | 2 | 2005 | 84 | 0.270 |
Why?
|
Adult | 131 | 2023 | 214052 | 0.260 |
Why?
|
Pseudolymphoma | 3 | 2014 | 30 | 0.260 |
Why?
|
Middle Aged | 135 | 2018 | 213390 | 0.260 |
Why?
|
Aged | 110 | 2018 | 163288 | 0.260 |
Why?
|
Neoplasm Staging | 32 | 2017 | 11031 | 0.260 |
Why?
|
Biopsy | 21 | 2018 | 6755 | 0.250 |
Why?
|
Male | 158 | 2019 | 350115 | 0.250 |
Why?
|
Proto-Oncogene Proteins | 5 | 2003 | 4554 | 0.250 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 4 | 1994 | 318 | 0.240 |
Why?
|
Female | 155 | 2019 | 380193 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 7 | 2012 | 1434 | 0.240 |
Why?
|
Prognosis | 41 | 2019 | 29060 | 0.240 |
Why?
|
Lymphoma, Primary Cutaneous Anaplastic Large Cell | 2 | 2014 | 9 | 0.230 |
Why?
|
Histiocytes | 4 | 2006 | 103 | 0.230 |
Why?
|
Salivary Gland Neoplasms | 2 | 1999 | 298 | 0.230 |
Why?
|
Genes, Immunoglobulin | 3 | 2019 | 291 | 0.230 |
Why?
|
HIV Seropositivity | 2 | 2007 | 971 | 0.230 |
Why?
|
Nose Neoplasms | 3 | 2003 | 246 | 0.230 |
Why?
|
Polymerase Chain Reaction | 18 | 2011 | 6171 | 0.230 |
Why?
|
Umbilical Cord | 1 | 2004 | 180 | 0.220 |
Why?
|
Lymphoma, Mantle-Cell | 3 | 2012 | 233 | 0.220 |
Why?
|
Immunoglobulin Heavy Chains | 6 | 2015 | 659 | 0.220 |
Why?
|
Mannose-Binding Lectins | 2 | 1994 | 100 | 0.220 |
Why?
|
Therapeutics | 1 | 2003 | 116 | 0.220 |
Why?
|
Neoplasm Proteins | 4 | 2001 | 3707 | 0.220 |
Why?
|
Diseases in Twins | 1 | 2004 | 449 | 0.210 |
Why?
|
Retinoblastoma Protein | 2 | 1996 | 705 | 0.210 |
Why?
|
Tumor Microenvironment | 1 | 2014 | 3590 | 0.210 |
Why?
|
Autoimmune Diseases | 5 | 2018 | 2134 | 0.210 |
Why?
|
Skin Diseases | 3 | 2015 | 1066 | 0.210 |
Why?
|
Paranasal Sinus Neoplasms | 3 | 2016 | 234 | 0.200 |
Why?
|
Transcription Factors | 9 | 2011 | 12207 | 0.200 |
Why?
|
Interferon Regulatory Factors | 5 | 2016 | 270 | 0.200 |
Why?
|
In Situ Hybridization | 10 | 2014 | 1950 | 0.200 |
Why?
|
Orbital Diseases | 3 | 1989 | 181 | 0.200 |
Why?
|
DNA-Binding Proteins | 9 | 2011 | 9647 | 0.200 |
Why?
|
Protein-Tyrosine Kinases | 5 | 2015 | 2455 | 0.200 |
Why?
|
Adolescent | 55 | 2019 | 85779 | 0.190 |
Why?
|
Carbon Sequestration | 1 | 2020 | 4 | 0.190 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 2010 | 49 | 0.190 |
Why?
|
Aged, 80 and over | 47 | 2018 | 57776 | 0.190 |
Why?
|
Forestry | 1 | 2020 | 10 | 0.190 |
Why?
|
Translocation, Genetic | 9 | 2014 | 1420 | 0.190 |
Why?
|
Exons | 3 | 2009 | 2439 | 0.190 |
Why?
|
Flow Cytometry | 12 | 2011 | 5974 | 0.190 |
Why?
|
Immunoglobulins | 8 | 1989 | 881 | 0.190 |
Why?
|
Radial Nerve | 1 | 2000 | 43 | 0.190 |
Why?
|
Trees | 1 | 2020 | 58 | 0.190 |
Why?
|
Spinal Nerves | 1 | 2000 | 86 | 0.180 |
Why?
|
Aerospace Medicine | 1 | 2010 | 84 | 0.180 |
Why?
|
Corpus Callosum | 1 | 2005 | 737 | 0.180 |
Why?
|
Cholesterol, HDL | 2 | 1997 | 1813 | 0.180 |
Why?
|
Lectins, C-Type | 2 | 1994 | 589 | 0.180 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 3 | 2001 | 43 | 0.180 |
Why?
|
Dextran Sulfate | 2 | 1997 | 236 | 0.180 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2000 | 122 | 0.180 |
Why?
|
Antigens, CD20 | 6 | 2008 | 199 | 0.170 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 1999 | 1520 | 0.170 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2010 | 131 | 0.170 |
Why?
|
Hepatitis, Autoimmune | 1 | 2010 | 141 | 0.170 |
Why?
|
Fibrin | 2 | 2017 | 506 | 0.170 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2018 | 30 | 0.170 |
Why?
|
Dendritic Cells, Follicular | 1 | 2018 | 53 | 0.160 |
Why?
|
DNA, Viral | 10 | 2005 | 2227 | 0.160 |
Why?
|
T-Lymphocyte Subsets | 3 | 2001 | 1837 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 6 | 2012 | 193 | 0.160 |
Why?
|
Leukemia, Myeloid | 3 | 1998 | 707 | 0.160 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 1996 | 285 | 0.160 |
Why?
|
Liver | 5 | 2010 | 7475 | 0.160 |
Why?
|
Neural Tube Defects | 2 | 2002 | 256 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-rel | 3 | 2007 | 71 | 0.150 |
Why?
|
Hyperlipidemias | 3 | 1998 | 789 | 0.150 |
Why?
|
Pathology, Surgical | 2 | 1996 | 155 | 0.150 |
Why?
|
Survival Rate | 18 | 2017 | 12788 | 0.150 |
Why?
|
Lupus Nephritis | 1 | 2010 | 310 | 0.150 |
Why?
|
Paraneoplastic Syndromes | 1 | 2018 | 151 | 0.150 |
Why?
|
Ultracentrifugation | 1 | 1997 | 182 | 0.150 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2001 | 880 | 0.150 |
Why?
|
Nasal Cavity | 2 | 2003 | 313 | 0.150 |
Why?
|
Sciatic Nerve | 1 | 2000 | 607 | 0.140 |
Why?
|
Virus Replication | 2 | 1995 | 2535 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2014 | 1821 | 0.140 |
Why?
|
Receptors, Antigen, B-Cell | 8 | 2004 | 548 | 0.140 |
Why?
|
Sarcoma, Kaposi | 3 | 2003 | 370 | 0.140 |
Why?
|
Introns | 4 | 1999 | 992 | 0.140 |
Why?
|
Infectious Mononucleosis | 2 | 2012 | 131 | 0.140 |
Why?
|
Thrombocytopenia | 2 | 2010 | 1178 | 0.140 |
Why?
|
Carbon | 1 | 2020 | 687 | 0.140 |
Why?
|
Sports | 1 | 2003 | 688 | 0.140 |
Why?
|
Spleen | 5 | 2005 | 2362 | 0.140 |
Why?
|
Europe | 8 | 2016 | 3338 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2010 | 8432 | 0.140 |
Why?
|
Mutation | 10 | 2023 | 29786 | 0.140 |
Why?
|
In Situ Hybridization, Fluorescence | 8 | 2012 | 2649 | 0.140 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 4 | 2010 | 92 | 0.140 |
Why?
|
Splenomegaly | 3 | 2007 | 190 | 0.140 |
Why?
|
Immunoassay | 2 | 1997 | 752 | 0.140 |
Why?
|
Combined Modality Therapy | 17 | 2010 | 8642 | 0.140 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2016 | 44 | 0.140 |
Why?
|
Nitric Oxide | 2 | 1995 | 2132 | 0.140 |
Why?
|
Survival Analysis | 13 | 2016 | 10252 | 0.140 |
Why?
|
Th2 Cells | 1 | 2001 | 1061 | 0.130 |
Why?
|
Gene Expression Profiling | 5 | 2006 | 9445 | 0.130 |
Why?
|
Mycosis Fungoides | 2 | 2012 | 163 | 0.130 |
Why?
|
Conjunctiva | 2 | 1989 | 494 | 0.130 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 2 | 2014 | 12 | 0.130 |
Why?
|
Orbital Pseudotumor | 1 | 2015 | 42 | 0.130 |
Why?
|
Ferrous Compounds | 1 | 1995 | 42 | 0.130 |
Why?
|
Tracheal Neoplasms | 2 | 1996 | 124 | 0.130 |
Why?
|
Dacryocystitis | 1 | 2015 | 70 | 0.130 |
Why?
|
Interferon-gamma | 2 | 1995 | 3207 | 0.130 |
Why?
|
Cell Proliferation | 5 | 2018 | 10483 | 0.130 |
Why?
|
Central Nervous System Neoplasms | 4 | 2008 | 895 | 0.130 |
Why?
|
Immunoglobulin G | 8 | 2015 | 4561 | 0.130 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1993 | 97 | 0.130 |
Why?
|
Multiple Myeloma | 4 | 2005 | 5181 | 0.120 |
Why?
|
Ki-67 Antigen | 4 | 2012 | 644 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 19 | 2017 | 11525 | 0.120 |
Why?
|
Hyperplasia | 6 | 1999 | 1185 | 0.120 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2015 | 1052 | 0.120 |
Why?
|
Palatine Tonsil | 2 | 2001 | 193 | 0.120 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2014 | 66 | 0.120 |
Why?
|
Genes, Viral | 2 | 1993 | 718 | 0.120 |
Why?
|
Plasmacytoma | 4 | 1995 | 183 | 0.120 |
Why?
|
Heavy Chain Disease | 1 | 2014 | 19 | 0.120 |
Why?
|
Base Sequence | 10 | 1999 | 12797 | 0.120 |
Why?
|
Citric Acid Cycle | 1 | 1995 | 232 | 0.120 |
Why?
|
S100 Proteins | 1 | 2014 | 259 | 0.120 |
Why?
|
Fatal Outcome | 5 | 2014 | 1851 | 0.120 |
Why?
|
Adenoids | 1 | 1993 | 33 | 0.120 |
Why?
|
Bone Marrow Transplantation | 2 | 2004 | 2765 | 0.120 |
Why?
|
Magnesium | 1 | 1997 | 813 | 0.120 |
Why?
|
Receptors, Cell Surface | 2 | 1994 | 2865 | 0.120 |
Why?
|
Immunoconjugates | 1 | 2001 | 901 | 0.120 |
Why?
|
Molecular Sequence Data | 14 | 2003 | 18111 | 0.110 |
Why?
|
RNA Cap Analogs | 1 | 1993 | 13 | 0.110 |
Why?
|
Child | 34 | 2023 | 77709 | 0.110 |
Why?
|
Follow-Up Studies | 24 | 2019 | 39052 | 0.110 |
Why?
|
Lung | 2 | 2003 | 9857 | 0.110 |
Why?
|
Cholesterol, LDL | 3 | 1998 | 2355 | 0.110 |
Why?
|
Cytokines | 2 | 2014 | 7323 | 0.110 |
Why?
|
DNA, Neoplasm | 7 | 2010 | 1758 | 0.110 |
Why?
|
Cyclin D2 | 1 | 2012 | 101 | 0.110 |
Why?
|
Stomach Neoplasms | 4 | 2004 | 1332 | 0.110 |
Why?
|
Scleroderma, Localized | 1 | 2013 | 79 | 0.110 |
Why?
|
Respiratory Hypersensitivity | 1 | 2014 | 274 | 0.110 |
Why?
|
Organ Transplantation | 3 | 1999 | 1140 | 0.110 |
Why?
|
Proto-Oncogenes | 1 | 1993 | 321 | 0.110 |
Why?
|
Immunoglobulin Light Chains | 4 | 2012 | 277 | 0.110 |
Why?
|
Mucous Membrane | 5 | 1993 | 673 | 0.110 |
Why?
|
Antigens, Surface | 7 | 1989 | 1663 | 0.100 |
Why?
|
Viral Proteins | 5 | 2003 | 1900 | 0.100 |
Why?
|
Cell Transformation, Viral | 1 | 1994 | 567 | 0.100 |
Why?
|
Lymphocytosis | 2 | 2011 | 119 | 0.100 |
Why?
|
Sclerosis | 5 | 2015 | 213 | 0.100 |
Why?
|
Gene Library | 3 | 2000 | 1074 | 0.100 |
Why?
|
Antigens, CD1 | 1 | 2014 | 437 | 0.100 |
Why?
|
Myeloid Differentiation Factor 88 | 2 | 2015 | 571 | 0.100 |
Why?
|
Recurrence | 9 | 2017 | 8340 | 0.100 |
Why?
|
Myeloproliferative Disorders | 4 | 2009 | 606 | 0.100 |
Why?
|
Specialization | 1 | 1996 | 776 | 0.100 |
Why?
|
Antibodies, Monoclonal | 15 | 1992 | 9274 | 0.100 |
Why?
|
Acquired Immunodeficiency Syndrome | 6 | 1991 | 2232 | 0.100 |
Why?
|
Vulvar Neoplasms | 2 | 1993 | 272 | 0.100 |
Why?
|
Nucleotidyltransferases | 1 | 1993 | 220 | 0.100 |
Why?
|
Transcription, Genetic | 4 | 2000 | 7721 | 0.100 |
Why?
|
Lymphoma, Large-Cell, Immunoblastic | 2 | 2009 | 26 | 0.100 |
Why?
|
Young Adult | 20 | 2019 | 56429 | 0.100 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1993 | 431 | 0.100 |
Why?
|
Kidney Transplantation | 6 | 2002 | 4251 | 0.100 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.100 |
Why?
|
Tumor Virus Infections | 1 | 1994 | 454 | 0.090 |
Why?
|
Mouth Neoplasms | 1 | 2016 | 601 | 0.090 |
Why?
|
Blotting, Southern | 4 | 2011 | 803 | 0.090 |
Why?
|
Nasal Mucosa | 1 | 1993 | 373 | 0.090 |
Why?
|
Goiter | 1 | 2010 | 87 | 0.090 |
Why?
|
Lymphadenitis | 2 | 1989 | 98 | 0.090 |
Why?
|
Cell Movement | 2 | 2001 | 5218 | 0.090 |
Why?
|
Thymus Gland | 3 | 2001 | 1267 | 0.090 |
Why?
|
Disease-Free Survival | 9 | 2016 | 6896 | 0.090 |
Why?
|
Frozen Sections | 3 | 1989 | 155 | 0.090 |
Why?
|
RNA, Viral | 7 | 2014 | 2901 | 0.090 |
Why?
|
Submandibular Gland Diseases | 1 | 2010 | 21 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2010 | 2943 | 0.090 |
Why?
|
Methyltransferases | 1 | 1993 | 367 | 0.090 |
Why?
|
Lymphatic Vessels | 1 | 2014 | 353 | 0.090 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 57 | 0.090 |
Why?
|
Parotid Diseases | 1 | 2010 | 46 | 0.090 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1991 | 294 | 0.090 |
Why?
|
Physician-Patient Relations | 1 | 2003 | 3229 | 0.090 |
Why?
|
Nausea | 2 | 2010 | 674 | 0.090 |
Why?
|
Codon | 1 | 2011 | 611 | 0.090 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 1991 | 97 | 0.090 |
Why?
|
Perforin | 2 | 2014 | 168 | 0.090 |
Why?
|
TNF Receptor-Associated Factor 1 | 2 | 2007 | 50 | 0.090 |
Why?
|
Monocytes | 2 | 1999 | 2596 | 0.090 |
Why?
|
Hamartoma | 1 | 1991 | 238 | 0.090 |
Why?
|
Staining and Labeling | 5 | 1995 | 1101 | 0.090 |
Why?
|
Bone Marrow Diseases | 1 | 1991 | 231 | 0.090 |
Why?
|
Uterine Cervical Diseases | 1 | 2010 | 77 | 0.090 |
Why?
|
Herpesvirus 1, Human | 1 | 1995 | 743 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2014 | 9240 | 0.090 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1989 | 43 | 0.090 |
Why?
|
Multienzyme Complexes | 1 | 1993 | 686 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2014 | 714 | 0.090 |
Why?
|
Immunoglobulin M | 7 | 2015 | 1537 | 0.090 |
Why?
|
Myocardium | 2 | 2010 | 4772 | 0.080 |
Why?
|
Phenotype | 12 | 2019 | 16367 | 0.080 |
Why?
|
Membrane Glycoproteins | 3 | 2004 | 3771 | 0.080 |
Why?
|
Predictive Value of Tests | 10 | 2018 | 15078 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2011 | 990 | 0.080 |
Why?
|
Cell Count | 4 | 2009 | 1856 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1525 | 0.080 |
Why?
|
Clone Cells | 5 | 2010 | 1692 | 0.080 |
Why?
|
Pruritus | 2 | 2010 | 361 | 0.080 |
Why?
|
Macrophages | 3 | 1994 | 5660 | 0.080 |
Why?
|
Uterine Diseases | 1 | 2010 | 135 | 0.080 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 1989 | 110 | 0.080 |
Why?
|
Kidney | 3 | 2010 | 7184 | 0.080 |
Why?
|
Receptors, Immunologic | 2 | 1992 | 1423 | 0.080 |
Why?
|
Brain Neoplasms | 7 | 2008 | 8861 | 0.080 |
Why?
|
Conjunctival Diseases | 1 | 1989 | 122 | 0.080 |
Why?
|
Mycoses | 1 | 1991 | 376 | 0.080 |
Why?
|
Child, Preschool | 17 | 2019 | 41005 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 1996 | 1988 | 0.080 |
Why?
|
International Cooperation | 4 | 2011 | 1420 | 0.080 |
Why?
|
Medicine | 1 | 1996 | 946 | 0.080 |
Why?
|
Mutation, Missense | 2 | 2009 | 2566 | 0.080 |
Why?
|
Bone Marrow Examination | 2 | 2009 | 157 | 0.080 |
Why?
|
Genome, Human | 2 | 2019 | 4420 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2014 | 2540 | 0.080 |
Why?
|
Information Systems | 1 | 1990 | 410 | 0.080 |
Why?
|
Megakaryocytes | 1 | 1991 | 545 | 0.080 |
Why?
|
Chromosomes, Human, Pair 11 | 3 | 1999 | 417 | 0.070 |
Why?
|
Gene Expression | 6 | 2012 | 7798 | 0.070 |
Why?
|
RNA, Messenger | 7 | 2012 | 13035 | 0.070 |
Why?
|
Treatment Outcome | 22 | 2017 | 63107 | 0.070 |
Why?
|
Histocytochemistry | 6 | 2006 | 719 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2003 | 2949 | 0.070 |
Why?
|
Amino Acid Sequence | 8 | 2003 | 13814 | 0.070 |
Why?
|
Incidental Findings | 1 | 2011 | 689 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 1993 | 1837 | 0.070 |
Why?
|
Chromosome Aberrations | 3 | 2009 | 1813 | 0.070 |
Why?
|
Thyroid Neoplasms | 3 | 2010 | 2282 | 0.070 |
Why?
|
Hemangioma | 1 | 1991 | 738 | 0.070 |
Why?
|
Janus Kinase 2 | 1 | 2009 | 528 | 0.070 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2007 | 374 | 0.070 |
Why?
|
Iatrogenic Disease | 1 | 2009 | 547 | 0.070 |
Why?
|
Myelodysplastic Syndromes | 2 | 2009 | 1352 | 0.070 |
Why?
|
Sensitivity and Specificity | 8 | 2007 | 14723 | 0.070 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2005 | 207 | 0.070 |
Why?
|
Blood Chemical Analysis | 2 | 2005 | 440 | 0.070 |
Why?
|
Triglycerides | 4 | 1998 | 2453 | 0.070 |
Why?
|
Mediastinal Cyst | 1 | 1985 | 29 | 0.070 |
Why?
|
Adoptive Transfer | 2 | 2014 | 844 | 0.070 |
Why?
|
Terminology as Topic | 5 | 2014 | 1547 | 0.070 |
Why?
|
Pathology | 2 | 2003 | 272 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 5 | 2014 | 1660 | 0.070 |
Why?
|
Carcinoma, Papillary | 1 | 2010 | 783 | 0.060 |
Why?
|
Oncogenes | 4 | 1995 | 1265 | 0.060 |
Why?
|
Cell Differentiation | 6 | 2003 | 11486 | 0.060 |
Why?
|
Body Mass Index | 1 | 2003 | 12721 | 0.060 |
Why?
|
Down-Regulation | 1 | 1992 | 3001 | 0.060 |
Why?
|
Histological Techniques | 2 | 1999 | 198 | 0.060 |
Why?
|
RNA Splicing | 1 | 1990 | 908 | 0.060 |
Why?
|
Karyotyping | 3 | 2010 | 1243 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3921 | 0.060 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 1991 | 1206 | 0.060 |
Why?
|
Hepatomegaly | 1 | 2004 | 85 | 0.060 |
Why?
|
Amino Acid Oxidoreductases | 2 | 1995 | 151 | 0.060 |
Why?
|
Mediastinal Diseases | 1 | 2005 | 89 | 0.060 |
Why?
|
Carcinoma | 2 | 1996 | 2375 | 0.060 |
Why?
|
Pyrazoles | 1 | 2015 | 1972 | 0.060 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2004 | 130 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 988 | 0.060 |
Why?
|
Cell Division | 3 | 2003 | 4569 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2005 | 640 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2010 | 921 | 0.060 |
Why?
|
Duodenal Neoplasms | 1 | 2004 | 106 | 0.060 |
Why?
|
Leukopenia | 1 | 2004 | 213 | 0.060 |
Why?
|
Ultrasonography | 4 | 2010 | 5984 | 0.060 |
Why?
|
False Negative Reactions | 3 | 2001 | 588 | 0.060 |
Why?
|
Fasting | 4 | 1998 | 1592 | 0.060 |
Why?
|
Quality Control | 2 | 1997 | 841 | 0.060 |
Why?
|
Hemoptysis | 1 | 2005 | 155 | 0.060 |
Why?
|
Thyroid Gland | 1 | 2010 | 1173 | 0.060 |
Why?
|
Methotrexate | 3 | 2005 | 1728 | 0.060 |
Why?
|
Prednisone | 6 | 2002 | 1574 | 0.060 |
Why?
|
Vaginal Neoplasms | 1 | 1984 | 106 | 0.060 |
Why?
|
Mice | 13 | 2014 | 81201 | 0.060 |
Why?
|
Arthritis | 1 | 1989 | 661 | 0.060 |
Why?
|
Hematologic Tests | 1 | 2004 | 240 | 0.060 |
Why?
|
Genes, bcl-2 | 1 | 2003 | 122 | 0.060 |
Why?
|
Helicobacter Infections | 2 | 2004 | 387 | 0.060 |
Why?
|
Oligodeoxyribonucleotides | 3 | 1994 | 708 | 0.060 |
Why?
|
Celiac Disease | 1 | 2011 | 785 | 0.060 |
Why?
|
Animals | 25 | 2014 | 168768 | 0.060 |
Why?
|
Phenytoin | 1 | 1983 | 197 | 0.060 |
Why?
|
Sjogren's Syndrome | 2 | 2010 | 234 | 0.060 |
Why?
|
DNA-Directed RNA Polymerases | 3 | 1994 | 371 | 0.060 |
Why?
|
Pneumonia | 2 | 2014 | 2133 | 0.060 |
Why?
|
Dermatomyositis | 1 | 2005 | 224 | 0.050 |
Why?
|
Pyrimidines | 1 | 2015 | 2943 | 0.050 |
Why?
|
Twins, Monozygotic | 1 | 2004 | 458 | 0.050 |
Why?
|
Histiocytic Disorders, Malignant | 1 | 2002 | 16 | 0.050 |
Why?
|
Vidarabine | 1 | 2004 | 345 | 0.050 |
Why?
|
Microtomy | 1 | 1982 | 47 | 0.050 |
Why?
|
Leukemia, Hairy Cell | 3 | 1995 | 82 | 0.050 |
Why?
|
Immunoglobulin kappa-Chains | 3 | 2002 | 173 | 0.050 |
Why?
|
Hospitals | 1 | 1996 | 3954 | 0.050 |
Why?
|
Stereotaxic Techniques | 1 | 2005 | 536 | 0.050 |
Why?
|
SOXC Transcription Factors | 2 | 2012 | 40 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 5 | 2003 | 2505 | 0.050 |
Why?
|
Submandibular Gland Neoplasms | 1 | 2001 | 11 | 0.050 |
Why?
|
Antibodies, Viral | 5 | 2003 | 3177 | 0.050 |
Why?
|
Time Factors | 12 | 2014 | 40075 | 0.050 |
Why?
|
Nitric Oxide Synthase | 2 | 1995 | 915 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2016 | 1581 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2000 | 5856 | 0.050 |
Why?
|
Submandibular Gland | 1 | 2001 | 86 | 0.050 |
Why?
|
Cell Cycle | 4 | 2001 | 2967 | 0.050 |
Why?
|
Peroxidase | 2 | 1998 | 611 | 0.050 |
Why?
|
Clathrin | 1 | 2003 | 267 | 0.050 |
Why?
|
Eosinophilia | 2 | 2009 | 541 | 0.050 |
Why?
|
United States | 12 | 2016 | 69872 | 0.050 |
Why?
|
Paraproteinemias | 2 | 2016 | 246 | 0.050 |
Why?
|
Central Nervous System Diseases | 2 | 2010 | 518 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2007 | 2969 | 0.050 |
Why?
|
Breast Neoplasms | 4 | 1999 | 20824 | 0.050 |
Why?
|
Molecular Biology | 2 | 1998 | 596 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2007 | 2513 | 0.050 |
Why?
|
Genome | 2 | 2000 | 1807 | 0.050 |
Why?
|
Blood Coagulation Disorders | 1 | 2004 | 337 | 0.050 |
Why?
|
Mice, Inbred A | 1 | 2001 | 248 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 2001 | 128 | 0.050 |
Why?
|
Movement Disorders | 1 | 2005 | 446 | 0.050 |
Why?
|
Chronic Disease | 7 | 2017 | 9145 | 0.050 |
Why?
|
Image Cytometry | 1 | 2001 | 54 | 0.050 |
Why?
|
Mucinosis, Follicular | 1 | 2000 | 8 | 0.050 |
Why?
|
Moths | 1 | 2001 | 87 | 0.050 |
Why?
|
Antigens, Differentiation | 3 | 2001 | 927 | 0.050 |
Why?
|
Vincristine | 4 | 2002 | 1039 | 0.050 |
Why?
|
Internationality | 2 | 2020 | 1002 | 0.050 |
Why?
|
Drosophila melanogaster | 2 | 2000 | 1708 | 0.050 |
Why?
|
Hepatolenticular Degeneration | 1 | 2010 | 69 | 0.050 |
Why?
|
Doxorubicin | 5 | 2002 | 2234 | 0.050 |
Why?
|
Jaundice | 1 | 2010 | 89 | 0.050 |
Why?
|
Epithelium | 2 | 1995 | 1679 | 0.050 |
Why?
|
Dendritic Cells | 2 | 2002 | 2725 | 0.050 |
Why?
|
Obesity | 1 | 2003 | 12746 | 0.050 |
Why?
|
Hepatitis, Viral, Human | 1 | 2010 | 138 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 1996 | 1572 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 2012 | 4805 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 8 | 2005 | 20130 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2009 | 1580 | 0.050 |
Why?
|
Genes, p16 | 1 | 2000 | 157 | 0.050 |
Why?
|
Global Warming | 1 | 2020 | 64 | 0.040 |
Why?
|
Plasma Exchange | 1 | 2010 | 152 | 0.040 |
Why?
|
Subtraction Technique | 1 | 2003 | 525 | 0.040 |
Why?
|
Hematopoietic System | 1 | 2000 | 109 | 0.040 |
Why?
|
Cardiac Tamponade | 1 | 2010 | 173 | 0.040 |
Why?
|
Uterine Neoplasms | 3 | 1989 | 1513 | 0.040 |
Why?
|
Parietal Lobe | 1 | 2005 | 838 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 2 | 2001 | 2751 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2010 | 11718 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 1989 | 2104 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1999 | 245 | 0.040 |
Why?
|
Transfection | 2 | 2001 | 5895 | 0.040 |
Why?
|
Back Pain | 1 | 2003 | 545 | 0.040 |
Why?
|
Pain | 2 | 2005 | 4988 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2003 | 3508 | 0.040 |
Why?
|
Transplantation, Homologous | 5 | 2001 | 4777 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1994 | 2839 | 0.040 |
Why?
|
Confusion | 1 | 2010 | 275 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5534 | 0.040 |
Why?
|
Cytodiagnosis | 2 | 1999 | 435 | 0.040 |
Why?
|
Thoracic Vertebrae | 1 | 2003 | 608 | 0.040 |
Why?
|
Radiography | 4 | 2010 | 7023 | 0.040 |
Why?
|
Liver Transplantation | 1 | 1989 | 2119 | 0.040 |
Why?
|
Neoplasms, Second Primary | 2 | 2004 | 1062 | 0.040 |
Why?
|
Biopsy, Needle | 3 | 2001 | 1641 | 0.040 |
Why?
|
Disease Progression | 6 | 2013 | 13286 | 0.040 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2010 | 272 | 0.040 |
Why?
|
Cohort Studies | 9 | 2019 | 40559 | 0.040 |
Why?
|
Conservation of Natural Resources | 1 | 2020 | 204 | 0.040 |
Why?
|
CHO Cells | 1 | 2001 | 1409 | 0.040 |
Why?
|
Gallstones | 1 | 2010 | 286 | 0.040 |
Why?
|
Leg | 1 | 2003 | 1116 | 0.040 |
Why?
|
Immunoglobulin lambda-Chains | 2 | 2002 | 87 | 0.040 |
Why?
|
MAP Kinase Kinase 4 | 1 | 1998 | 148 | 0.040 |
Why?
|
Terminal Care | 1 | 2010 | 1694 | 0.040 |
Why?
|
Interleukin-18 | 1 | 1999 | 249 | 0.040 |
Why?
|
Phosphotungstic Acid | 1 | 1997 | 6 | 0.040 |
Why?
|
North America | 2 | 2014 | 1249 | 0.040 |
Why?
|
Cricetinae | 2 | 2001 | 2475 | 0.040 |
Why?
|
Chemokines, CXC | 1 | 1999 | 422 | 0.040 |
Why?
|
Age Factors | 6 | 2016 | 18373 | 0.040 |
Why?
|
Infant | 7 | 2019 | 35134 | 0.040 |
Why?
|
Myasthenia Gravis | 2 | 1993 | 199 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2015 | 6539 | 0.040 |
Why?
|
Cell Compartmentation | 1 | 1998 | 402 | 0.040 |
Why?
|
Acute Disease | 3 | 2010 | 7147 | 0.040 |
Why?
|
Syndrome | 3 | 1994 | 3252 | 0.040 |
Why?
|
Cyclophosphamide | 4 | 2002 | 2242 | 0.040 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1999 | 255 | 0.040 |
Why?
|
Headache | 1 | 2005 | 1226 | 0.040 |
Why?
|
Cytidine Deaminase | 1 | 2019 | 252 | 0.040 |
Why?
|
Age Distribution | 1 | 2003 | 2902 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2006 | 4386 | 0.040 |
Why?
|
Magnesium Chloride | 1 | 1996 | 32 | 0.040 |
Why?
|
Capsid Proteins | 2 | 1991 | 479 | 0.040 |
Why?
|
Asthma | 2 | 2014 | 6010 | 0.040 |
Why?
|
Postoperative Complications | 3 | 1999 | 15297 | 0.040 |
Why?
|
Gene Deletion | 2 | 2004 | 2751 | 0.040 |
Why?
|
Blotting, Northern | 1 | 1998 | 1581 | 0.040 |
Why?
|
Templates, Genetic | 2 | 1994 | 211 | 0.040 |
Why?
|
Chemical Precipitation | 1 | 1996 | 179 | 0.030 |
Why?
|
NF-kappa B | 1 | 2005 | 2499 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2012 | 5524 | 0.030 |
Why?
|
Fallopian Tube Neoplasms | 1 | 1999 | 324 | 0.030 |
Why?
|
Heart Transplantation | 1 | 1989 | 3112 | 0.030 |
Why?
|
DNA Copy Number Variations | 2 | 2016 | 1941 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2003 | 1660 | 0.030 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 1 | 1995 | 23 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2001 | 5096 | 0.030 |
Why?
|
Immunoblotting | 2 | 2003 | 1683 | 0.030 |
Why?
|
Camptothecin | 1 | 1999 | 576 | 0.030 |
Why?
|
Genotype | 4 | 1993 | 12952 | 0.030 |
Why?
|
Cell Line | 3 | 1995 | 16000 | 0.030 |
Why?
|
Tricarboxylic Acids | 1 | 1995 | 29 | 0.030 |
Why?
|
Penicillamine | 1 | 1995 | 59 | 0.030 |
Why?
|
Protein Kinases | 2 | 2004 | 1640 | 0.030 |
Why?
|
Indicators and Reagents | 1 | 1996 | 462 | 0.030 |
Why?
|
Shock, Cardiogenic | 1 | 2010 | 688 | 0.030 |
Why?
|
omega-N-Methylarginine | 1 | 1995 | 111 | 0.030 |
Why?
|
Bilirubin | 1 | 1997 | 425 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 738 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 647 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 610 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5181 | 0.030 |
Why?
|
Cell Shape | 1 | 2016 | 375 | 0.030 |
Why?
|
Bone Marrow Neoplasms | 1 | 1996 | 104 | 0.030 |
Why?
|
Ibuprofen | 1 | 1996 | 236 | 0.030 |
Why?
|
Demography | 2 | 1998 | 1655 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2019 | 25628 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1996 | 224 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2014 | 47 | 0.030 |
Why?
|
Gene Frequency | 2 | 2013 | 3587 | 0.030 |
Why?
|
Syndecan-1 | 2 | 2007 | 165 | 0.030 |
Why?
|
Receptors, Complement 3d | 2 | 2007 | 118 | 0.030 |
Why?
|
Transcription Factors, General | 1 | 1994 | 11 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2014 | 21833 | 0.030 |
Why?
|
Remission Induction | 3 | 2002 | 2385 | 0.030 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2014 | 73 | 0.030 |
Why?
|
Abdomen | 1 | 2010 | 1118 | 0.030 |
Why?
|
Apoptosis | 4 | 2005 | 9724 | 0.030 |
Why?
|
Muridae | 1 | 1994 | 61 | 0.030 |
Why?
|
Spermatic Cord | 1 | 1994 | 25 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1999 | 1085 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2013 | 4185 | 0.030 |
Why?
|
Thyroidectomy | 3 | 2010 | 879 | 0.030 |
Why?
|
Macrophages, Peritoneal | 1 | 1995 | 251 | 0.030 |
Why?
|
Radioimmunotherapy | 1 | 2014 | 91 | 0.030 |
Why?
|
Ricin | 1 | 1994 | 72 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 1995 | 299 | 0.030 |
Why?
|
Tongue Neoplasms | 1 | 1996 | 180 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2010 | 1064 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 376 | 0.030 |
Why?
|
Antibodies | 2 | 1996 | 2460 | 0.030 |
Why?
|
Specimen Handling | 1 | 1999 | 694 | 0.030 |
Why?
|
Genital Neoplasms, Male | 1 | 1994 | 74 | 0.030 |
Why?
|
Cytarabine | 2 | 1993 | 692 | 0.030 |
Why?
|
Promoter Regions, Genetic | 3 | 1994 | 5867 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4328 | 0.030 |
Why?
|
Lymphatic Metastasis | 4 | 2012 | 2924 | 0.030 |
Why?
|
Ascorbic Acid | 1 | 1997 | 651 | 0.030 |
Why?
|
Ploidies | 2 | 2006 | 281 | 0.030 |
Why?
|
Chest Pain | 1 | 2010 | 1114 | 0.030 |
Why?
|
Hypothyroidism | 2 | 2010 | 658 | 0.030 |
Why?
|
Fibroblasts | 3 | 2011 | 4162 | 0.030 |
Why?
|
Cyclin D3 | 1 | 2012 | 55 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2010 | 1873 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 1993 | 306 | 0.030 |
Why?
|
Cell Lineage | 2 | 2014 | 2504 | 0.030 |
Why?
|
Kinetics | 2 | 2020 | 6476 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1998 | 1284 | 0.030 |
Why?
|
Transcriptional Elongation Factors | 1 | 1994 | 166 | 0.030 |
Why?
|
Peritoneal Neoplasms | 1 | 1999 | 665 | 0.030 |
Why?
|
Splenectomy | 2 | 1984 | 395 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2006 | 4479 | 0.030 |
Why?
|
Magnetics | 1 | 1996 | 606 | 0.030 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2013 | 242 | 0.030 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 1993 | 140 | 0.030 |
Why?
|
Bone Lengthening | 1 | 1992 | 19 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1996 | 671 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 2000 | 4320 | 0.030 |
Why?
|
Genetic Markers | 2 | 2012 | 2634 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 1994 | 791 | 0.030 |
Why?
|
DNA Replication | 2 | 2000 | 1399 | 0.030 |
Why?
|
Neutropenia | 3 | 2002 | 895 | 0.030 |
Why?
|
Hepatitis B Antibodies | 1 | 2013 | 159 | 0.030 |
Why?
|
Granzymes | 1 | 2014 | 271 | 0.030 |
Why?
|
Mannose | 1 | 1992 | 124 | 0.030 |
Why?
|
Autoantibodies | 1 | 2010 | 2036 | 0.030 |
Why?
|
Epididymis | 1 | 1994 | 227 | 0.030 |
Why?
|
Agranulocytosis | 2 | 1982 | 101 | 0.030 |
Why?
|
3T3 Cells | 1 | 1994 | 1101 | 0.030 |
Why?
|
External Fixators | 1 | 1992 | 94 | 0.030 |
Why?
|
Genes, T-Cell Receptor | 1 | 2011 | 29 | 0.030 |
Why?
|
Rosette Formation | 5 | 1985 | 153 | 0.030 |
Why?
|
Bone Wires | 1 | 1992 | 122 | 0.030 |
Why?
|
Periodicals as Topic | 1 | 2003 | 1431 | 0.030 |
Why?
|
Cryptococcus | 1 | 1991 | 29 | 0.030 |
Why?
|
Leukocyte Count | 2 | 1999 | 1588 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2005 | 3616 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 1999 | 1677 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2013 | 305 | 0.030 |
Why?
|
Histoplasma | 1 | 1991 | 41 | 0.030 |
Why?
|
Parathyroid Diseases | 1 | 1991 | 48 | 0.030 |
Why?
|
Antineoplastic Agents | 5 | 2013 | 13693 | 0.020 |
Why?
|
Genetic Testing | 1 | 2004 | 3444 | 0.020 |
Why?
|
Antibody Specificity | 1 | 1993 | 1095 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10388 | 0.020 |
Why?
|
TATA Box | 1 | 1991 | 128 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2003 | 6386 | 0.020 |
Why?
|
Maryland | 1 | 2011 | 276 | 0.020 |
Why?
|
Anemia | 1 | 2010 | 1503 | 0.020 |
Why?
|
Antibodies, Neoplasm | 2 | 1999 | 286 | 0.020 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 113 | 0.020 |
Why?
|
Arginine | 1 | 1995 | 944 | 0.020 |
Why?
|
Virus Activation | 1 | 2013 | 319 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 2 | 2006 | 1094 | 0.020 |
Why?
|
Reference Values | 2 | 1997 | 4982 | 0.020 |
Why?
|
Data Collection | 1 | 2020 | 3339 | 0.020 |
Why?
|
Bone Nails | 1 | 1992 | 219 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2000 | 1418 | 0.020 |
Why?
|
Transplantation Immunology | 2 | 1989 | 546 | 0.020 |
Why?
|
Retrospective Studies | 9 | 2010 | 77460 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 427 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 1995 | 976 | 0.020 |
Why?
|
Peru | 1 | 1993 | 881 | 0.020 |
Why?
|
Information Services | 1 | 1992 | 244 | 0.020 |
Why?
|
Cysteine | 1 | 1995 | 873 | 0.020 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2010 | 101 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 295 | 0.020 |
Why?
|
Contig Mapping | 2 | 2000 | 54 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 7914 | 0.020 |
Why?
|
Necrosis | 2 | 2012 | 1643 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2011 | 1771 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2015 | 727 | 0.020 |
Why?
|
HeLa Cells | 2 | 1994 | 3130 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 677 | 0.020 |
Why?
|
Proteome | 1 | 2000 | 1798 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 2003 | 6313 | 0.020 |
Why?
|
Lymph Node Excision | 2 | 2010 | 1262 | 0.020 |
Why?
|
Belgium | 1 | 2009 | 103 | 0.020 |
Why?
|
Adenine | 1 | 2015 | 936 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2011 | 500 | 0.020 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1989 | 31 | 0.020 |
Why?
|
Titanium | 1 | 1992 | 494 | 0.020 |
Why?
|
Hepatitis B virus | 1 | 2013 | 513 | 0.020 |
Why?
|
Myelodysplastic-Myeloproliferative Diseases | 1 | 2009 | 13 | 0.020 |
Why?
|
Stomach Diseases | 1 | 1990 | 134 | 0.020 |
Why?
|
Preleukemia | 1 | 2009 | 35 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2013 | 1423 | 0.020 |
Why?
|
Radiotherapy | 2 | 2008 | 1533 | 0.020 |
Why?
|
Atrophy | 1 | 2014 | 1584 | 0.020 |
Why?
|
Genes, T-Cell Receptor gamma | 1 | 2008 | 16 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18034 | 0.020 |
Why?
|
Endothelium | 1 | 1991 | 778 | 0.020 |
Why?
|
Eye Diseases | 2 | 2005 | 669 | 0.020 |
Why?
|
Hemoglobins | 1 | 2015 | 1532 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5172 | 0.020 |
Why?
|
Immunoglobulin A | 2 | 1989 | 995 | 0.020 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2008 | 71 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 1995 | 4740 | 0.020 |
Why?
|
Stents | 1 | 2010 | 3282 | 0.020 |
Why?
|
Microscopy, Electron | 2 | 2002 | 2646 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2002 | 780 | 0.020 |
Why?
|
Insect Proteins | 2 | 2000 | 258 | 0.020 |
Why?
|
Helicobacter pylori | 2 | 2004 | 383 | 0.020 |
Why?
|
Microcirculation | 1 | 2013 | 1287 | 0.020 |
Why?
|
Blood Vessels | 1 | 2014 | 1125 | 0.020 |
Why?
|
Boston | 2 | 2011 | 9312 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2001 | 9735 | 0.020 |
Why?
|
Antigens, Viral | 2 | 1991 | 1035 | 0.020 |
Why?
|
Plants | 1 | 1990 | 316 | 0.020 |
Why?
|
Radiotherapy Dosage | 3 | 2003 | 2879 | 0.020 |
Why?
|
DNA Nucleotidylexotransferase | 2 | 1998 | 64 | 0.020 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1991 | 286 | 0.020 |
Why?
|
Angiolymphoid Hyperplasia with Eosinophilia | 1 | 1987 | 5 | 0.020 |
Why?
|
Immunologic Tests | 1 | 2008 | 103 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2010 | 553 | 0.020 |
Why?
|
Echocardiography | 1 | 2010 | 5099 | 0.020 |
Why?
|
Advance Directives | 1 | 2010 | 246 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2017 | 21748 | 0.020 |
Why?
|
Cells, Cultured | 2 | 1995 | 19233 | 0.020 |
Why?
|
Propanols | 1 | 1987 | 10 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 1996 | 1178 | 0.020 |
Why?
|
von Willebrand Factor | 1 | 1991 | 669 | 0.020 |
Why?
|
Thalidomide | 1 | 2013 | 890 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2011 | 423 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 1994 | 806 | 0.020 |
Why?
|
Brain Stem | 1 | 1993 | 846 | 0.020 |
Why?
|
Mastocytosis, Systemic | 1 | 2009 | 100 | 0.020 |
Why?
|
Tissue Donors | 3 | 1995 | 2241 | 0.020 |
Why?
|
Cardiolipins | 1 | 1987 | 88 | 0.020 |
Why?
|
Hepatitis B | 1 | 2013 | 695 | 0.020 |
Why?
|
Deltaretrovirus Infections | 1 | 1987 | 26 | 0.020 |
Why?
|
Heart | 1 | 2010 | 4464 | 0.020 |
Why?
|
Thyroid Diseases | 1 | 2010 | 379 | 0.020 |
Why?
|
Electrocardiography | 1 | 2010 | 6442 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6459 | 0.020 |
Why?
|
Hospitals, General | 1 | 2011 | 749 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 2010 | 1032 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2011 | 3480 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2001 | 19905 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2029 | 0.020 |
Why?
|
Uveal Neoplasms | 1 | 1989 | 310 | 0.020 |
Why?
|
Cytoplasm | 1 | 1991 | 1536 | 0.020 |
Why?
|
Addison Disease | 1 | 1987 | 48 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2002 | 3524 | 0.020 |
Why?
|
Piperidines | 1 | 2015 | 1602 | 0.020 |
Why?
|
Ovarian Neoplasms | 2 | 1999 | 4839 | 0.020 |
Why?
|
Mastectomy | 1 | 1995 | 1793 | 0.020 |
Why?
|
Asia | 1 | 2008 | 609 | 0.020 |
Why?
|
Massachusetts | 2 | 1996 | 8662 | 0.020 |
Why?
|
Tibia | 1 | 1992 | 1077 | 0.020 |
Why?
|
Immunity | 2 | 2004 | 1014 | 0.020 |
Why?
|
Hypercalcemia | 1 | 1989 | 409 | 0.020 |
Why?
|
Stomach | 1 | 1990 | 697 | 0.020 |
Why?
|
Immunochemistry | 1 | 1985 | 124 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2011 | 576 | 0.020 |
Why?
|
Viruses | 1 | 1990 | 375 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2012 | 1405 | 0.020 |
Why?
|
Prevalence | 1 | 2003 | 15221 | 0.020 |
Why?
|
Yersinia Infections | 1 | 1985 | 9 | 0.020 |
Why?
|
Bronchial Neoplasms | 1 | 1986 | 112 | 0.020 |
Why?
|
Decision Making | 1 | 2000 | 3888 | 0.020 |
Why?
|
Lysosomes | 1 | 1991 | 893 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 1987 | 471 | 0.020 |
Why?
|
Hypothalamus | 1 | 1991 | 1063 | 0.020 |
Why?
|
Phototherapy | 1 | 2008 | 377 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2725 | 0.020 |
Why?
|
Thyroiditis | 1 | 2005 | 85 | 0.020 |
Why?
|
Foodborne Diseases | 1 | 1985 | 39 | 0.020 |
Why?
|
DNA, Recombinant | 1 | 1985 | 476 | 0.020 |
Why?
|
International Agencies | 1 | 2005 | 240 | 0.020 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 1984 | 66 | 0.020 |
Why?
|
Phosphorylation | 1 | 1996 | 8436 | 0.020 |
Why?
|
Antigen-Antibody Reactions | 1 | 1984 | 363 | 0.020 |
Why?
|
Antilymphocyte Serum | 2 | 1980 | 492 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 1990 | 868 | 0.020 |
Why?
|
Technetium | 1 | 1984 | 334 | 0.020 |
Why?
|
Homosexuality | 1 | 1985 | 262 | 0.020 |
Why?
|
Tonsillar Neoplasms | 1 | 1984 | 51 | 0.020 |
Why?
|
Models, Biological | 2 | 2008 | 9584 | 0.010 |
Why?
|
Disease Management | 1 | 2015 | 2460 | 0.010 |
Why?
|
Sulfur | 1 | 1984 | 166 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 2015 | 13991 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1985 | 645 | 0.010 |
Why?
|
Pregnancy | 2 | 1999 | 29144 | 0.010 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2007 | 260 | 0.010 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2008 | 602 | 0.010 |
Why?
|
Toxoplasmosis | 1 | 1984 | 91 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 4751 | 0.010 |
Why?
|
Binding Sites | 1 | 1992 | 6111 | 0.010 |
Why?
|
Meningeal Neoplasms | 2 | 2008 | 1241 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1152 | 0.010 |
Why?
|
Demyelinating Diseases | 1 | 1986 | 354 | 0.010 |
Why?
|
Models, Molecular | 1 | 1994 | 5451 | 0.010 |
Why?
|
Models, Genetic | 1 | 1994 | 3493 | 0.010 |
Why?
|
Syndecans | 1 | 2003 | 79 | 0.010 |
Why?
|
Drug Monitoring | 2 | 2002 | 956 | 0.010 |
Why?
|
Leiomyoma | 1 | 1989 | 730 | 0.010 |
Why?
|
Lymphography | 1 | 1984 | 201 | 0.010 |
Why?
|
Gastroenteritis | 1 | 1985 | 245 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3646 | 0.010 |
Why?
|
Murine Acquired Immunodeficiency Syndrome | 1 | 2002 | 4 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2001 | 5445 | 0.010 |
Why?
|
Receptors, Complement | 2 | 1981 | 264 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1992 | 6621 | 0.010 |
Why?
|
Gastritis | 1 | 2004 | 196 | 0.010 |
Why?
|
Immune Sera | 1 | 1983 | 641 | 0.010 |
Why?
|
Hepatitis C | 1 | 2013 | 1591 | 0.010 |
Why?
|
HIV Infections | 1 | 2009 | 16715 | 0.010 |
Why?
|
Muscle Weakness | 1 | 2005 | 413 | 0.010 |
Why?
|
Oxidative Phosphorylation | 1 | 2004 | 481 | 0.010 |
Why?
|
RNA, Nuclear | 1 | 2002 | 30 | 0.010 |
Why?
|
Epitope Mapping | 1 | 2003 | 311 | 0.010 |
Why?
|
Infarction | 1 | 1983 | 244 | 0.010 |
Why?
|
STAT1 Transcription Factor | 1 | 2003 | 320 | 0.010 |
Why?
|
Thromboembolism | 1 | 1988 | 987 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2003 | 876 | 0.010 |
Why?
|
Incidence | 2 | 1998 | 20952 | 0.010 |
Why?
|
Risk Assessment | 2 | 2016 | 23336 | 0.010 |
Why?
|
Leukemic Infiltration | 1 | 2001 | 48 | 0.010 |
Why?
|
Placenta | 1 | 1991 | 1699 | 0.010 |
Why?
|
Consensus | 1 | 2011 | 2960 | 0.010 |
Why?
|
Hybridomas | 1 | 1983 | 452 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 443 | 0.010 |
Why?
|
Freezing | 1 | 1982 | 303 | 0.010 |
Why?
|
Endothelium, Vascular | 2 | 1991 | 4459 | 0.010 |
Why?
|
Genes, p53 | 1 | 2004 | 755 | 0.010 |
Why?
|
Mitosis | 2 | 2001 | 1208 | 0.010 |
Why?
|
Epithelial Cells | 1 | 1993 | 3690 | 0.010 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1987 | 740 | 0.010 |
Why?
|
Gammaherpesvirinae | 1 | 2001 | 27 | 0.010 |
Why?
|
Interleukin-13 | 1 | 2003 | 389 | 0.010 |
Why?
|
Edema | 1 | 2005 | 789 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1985 | 1475 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2009 | 1376 | 0.010 |
Why?
|
Exanthema | 1 | 2005 | 501 | 0.010 |
Why?
|
Sheep | 2 | 1981 | 1437 | 0.010 |
Why?
|
Hypertension | 1 | 2010 | 8479 | 0.010 |
Why?
|
Orbit | 1 | 1984 | 426 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 2001 | 331 | 0.010 |
Why?
|
Capsid | 2 | 1994 | 437 | 0.010 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1986 | 685 | 0.010 |
Why?
|
Etoposide | 1 | 2002 | 641 | 0.010 |
Why?
|
Genes, Duplicate | 1 | 2000 | 33 | 0.010 |
Why?
|
Gene Expression Regulation, Viral | 2 | 1994 | 442 | 0.010 |
Why?
|
Euchromatin | 1 | 2000 | 56 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1984 | 2031 | 0.010 |
Why?
|
Congresses as Topic | 1 | 2005 | 764 | 0.010 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1999 | 118 | 0.010 |
Why?
|
Connective Tissue | 1 | 1982 | 420 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2002 | 915 | 0.010 |
Why?
|
Glycerol | 1 | 2001 | 278 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2003 | 705 | 0.010 |
Why?
|
Signal Transduction | 4 | 2004 | 23404 | 0.010 |
Why?
|
Proteoglycans | 1 | 2003 | 837 | 0.010 |
Why?
|
Prospective Studies | 2 | 2015 | 53290 | 0.010 |
Why?
|
Algorithms | 2 | 2015 | 13882 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 2050 | 0.010 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 2 | 1991 | 150 | 0.010 |
Why?
|
Chemokine CXCL9 | 1 | 1999 | 132 | 0.010 |
Why?
|
Genital Neoplasms, Female | 1 | 1985 | 523 | 0.010 |
Why?
|
Platelet Count | 1 | 2002 | 780 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14561 | 0.010 |
Why?
|
Helminth Proteins | 1 | 2000 | 171 | 0.010 |
Why?
|
Genes, Insect | 1 | 2000 | 268 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1620 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2001 | 583 | 0.010 |
Why?
|
Culture Media | 1 | 2001 | 909 | 0.010 |
Why?
|
Cholesterol | 2 | 1998 | 2919 | 0.010 |
Why?
|
Family Health | 1 | 2004 | 1281 | 0.010 |
Why?
|
Swine, Miniature | 1 | 2001 | 961 | 0.010 |
Why?
|
Chemokine CCL5 | 1 | 1999 | 209 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2001 | 980 | 0.010 |
Why?
|
Fibronectins | 1 | 1982 | 726 | 0.010 |
Why?
|
Gastrectomy | 2 | 1999 | 663 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 17446 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1991 | 2249 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 2 | 1988 | 2020 | 0.010 |
Why?
|
Cell Cycle Proteins | 2 | 2004 | 3464 | 0.010 |
Why?
|
Chemokine CXCL10 | 1 | 1999 | 305 | 0.010 |
Why?
|
Risk Factors | 3 | 2018 | 72296 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 2 | 1990 | 1375 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 1995 | 4262 | 0.010 |
Why?
|
Cytogenetics | 1 | 1998 | 203 | 0.010 |
Why?
|
Venules | 2 | 1988 | 165 | 0.010 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2000 | 419 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 35425 | 0.010 |
Why?
|
Heterochromatin | 1 | 2000 | 296 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2004 | 2715 | 0.010 |
Why?
|
Health Policy | 1 | 2010 | 2661 | 0.010 |
Why?
|
Genetics, Medical | 1 | 2000 | 338 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10637 | 0.010 |
Why?
|
Neoplasms | 2 | 2003 | 21696 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 494 | 0.010 |
Why?
|
Chimera | 1 | 1998 | 485 | 0.010 |
Why?
|
Multigene Family | 1 | 2000 | 1102 | 0.010 |
Why?
|
Caspases | 1 | 1999 | 928 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4153 | 0.010 |
Why?
|
Bronchoscopy | 2 | 1996 | 862 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2001 | 2256 | 0.010 |
Why?
|
Drug Stability | 1 | 1996 | 291 | 0.010 |
Why?
|
Mathematics | 1 | 1997 | 728 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 452 | 0.010 |
Why?
|
Pedigree | 1 | 2004 | 4642 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3873 | 0.010 |
Why?
|
Fungal Proteins | 1 | 2000 | 912 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2009 | 5023 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 1985 | 1771 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 1997 | 659 | 0.010 |
Why?
|
Biological Transport | 1 | 2000 | 2120 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12356 | 0.010 |
Why?
|
Genetic Diseases, Inborn | 1 | 2000 | 587 | 0.010 |
Why?
|
Hot Temperature | 1 | 2001 | 1356 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 697 | 0.010 |
Why?
|
Cations, Divalent | 1 | 1994 | 166 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2001 | 1868 | 0.010 |
Why?
|
Sex Factors | 2 | 1999 | 10400 | 0.010 |
Why?
|
Models, Animal | 1 | 2001 | 2173 | 0.010 |
Why?
|
Biological Evolution | 1 | 2000 | 1077 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 1984 | 4851 | 0.010 |
Why?
|
DNA Damage | 1 | 2004 | 2432 | 0.010 |
Why?
|
Treatment Failure | 1 | 2000 | 2618 | 0.010 |
Why?
|
Liver Diseases | 1 | 1982 | 1253 | 0.010 |
Why?
|
Collagen | 1 | 1982 | 2688 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 2850 | 0.010 |
Why?
|
Trans-Activators | 1 | 2003 | 2926 | 0.010 |
Why?
|
Molecular Probes | 1 | 1995 | 316 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2000 | 3144 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 3848 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1989 | 5709 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1998 | 1680 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2000 | 2126 | 0.010 |
Why?
|
Immunotherapy | 1 | 2008 | 4446 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15520 | 0.010 |
Why?
|
Denmark | 1 | 1994 | 738 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1998 | 3702 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 1995 | 769 | 0.010 |
Why?
|
Skin | 1 | 2005 | 4372 | 0.010 |
Why?
|
Health Status | 1 | 2005 | 4034 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 1801 | 0.010 |
Why?
|
Rehabilitation | 1 | 1972 | 134 | 0.010 |
Why?
|
Graft vs Host Reaction | 1 | 1971 | 104 | 0.010 |
Why?
|
Cytosine Nucleotides | 1 | 1970 | 11 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12244 | 0.010 |
Why?
|
Administration, Oral | 1 | 1999 | 3914 | 0.010 |
Why?
|
Diagnosis | 1 | 1992 | 154 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1997 | 1602 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1991 | 878 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1979 | 1170 | 0.010 |
Why?
|
Seizures | 1 | 1983 | 2859 | 0.010 |
Why?
|
Intraoperative Period | 1 | 1992 | 520 | 0.010 |
Why?
|
Forecasting | 1 | 2000 | 2951 | 0.010 |
Why?
|
Sarcoma | 1 | 2002 | 1897 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1991 | 769 | 0.010 |
Why?
|
DNA Repair | 1 | 2000 | 2046 | 0.010 |
Why?
|
Erythrocytes | 1 | 1980 | 2455 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 1994 | 976 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4925 | 0.010 |
Why?
|
Calcium | 1 | 2003 | 5755 | 0.010 |
Why?
|
Fibula | 1 | 1992 | 269 | 0.010 |
Why?
|
Skin Transplantation | 2 | 1972 | 1074 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 1994 | 847 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 1996 | 1257 | 0.010 |
Why?
|
Glucose | 1 | 2001 | 4398 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16690 | 0.010 |
Why?
|
Cause of Death | 1 | 1999 | 3582 | 0.000 |
Why?
|
Dyspnea | 1 | 1996 | 1303 | 0.000 |
Why?
|
Chromatin | 1 | 2000 | 2933 | 0.000 |
Why?
|
Proteins | 1 | 2003 | 6100 | 0.000 |
Why?
|
Aminopyrine | 1 | 1987 | 8 | 0.000 |
Why?
|
1-Propanol | 1 | 1987 | 15 | 0.000 |
Why?
|
Computational Biology | 1 | 2000 | 3519 | 0.000 |
Why?
|
Genes | 1 | 1991 | 1893 | 0.000 |
Why?
|
Fludrocortisone | 1 | 1987 | 25 | 0.000 |
Why?
|
Chromosomes | 1 | 1970 | 596 | 0.000 |
Why?
|
Homeostasis | 1 | 1998 | 3339 | 0.000 |
Why?
|
Cortisone | 1 | 1987 | 89 | 0.000 |
Why?
|
Breath Tests | 1 | 1987 | 280 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 7182 | 0.000 |
Why?
|
Yersinia enterocolitica | 1 | 1985 | 13 | 0.000 |
Why?
|
Vulvitis | 1 | 1985 | 8 | 0.000 |
Why?
|
Capillaries | 1 | 1988 | 773 | 0.000 |
Why?
|
Uterine Cervicitis | 1 | 1985 | 30 | 0.000 |
Why?
|
Food Microbiology | 1 | 1985 | 78 | 0.000 |
Why?
|
Endometritis | 1 | 1985 | 48 | 0.000 |
Why?
|
Cobalt Radioisotopes | 1 | 1984 | 76 | 0.000 |
Why?
|
Washington | 1 | 1985 | 313 | 0.000 |
Why?
|
Actuarial Analysis | 1 | 1984 | 378 | 0.000 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1991 | 808 | 0.000 |
Why?
|
Cholecalciferol | 1 | 1989 | 535 | 0.000 |
Why?
|
Equipment Design | 1 | 1992 | 3582 | 0.000 |
Why?
|
Bacterial Vaccines | 1 | 1986 | 403 | 0.000 |
Why?
|
Drug Synergism | 1 | 1987 | 1794 | 0.000 |
Why?
|
Influenza A virus | 1 | 1986 | 456 | 0.000 |
Why?
|
Encephalitis | 1 | 1986 | 425 | 0.000 |
Why?
|
Pneumococcal Vaccines | 1 | 1986 | 391 | 0.000 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1988 | 934 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1990 | 2259 | 0.000 |
Why?
|
Airway Obstruction | 1 | 1986 | 664 | 0.000 |
Why?
|
Rabbits | 1 | 1987 | 4894 | 0.000 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1981 | 307 | 0.000 |
Why?
|
Epidemiologic Methods | 1 | 1985 | 1364 | 0.000 |
Why?
|
Feces | 1 | 1985 | 1401 | 0.000 |
Why?
|
RNA | 1 | 1989 | 2749 | 0.000 |
Why?
|
Vascular Diseases | 1 | 1987 | 1161 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1992 | 3531 | 0.000 |
Why?
|
Biliary Tract Diseases | 1 | 1979 | 161 | 0.000 |
Why?
|
Influenza Vaccines | 1 | 1986 | 738 | 0.000 |
Why?
|
DNA | 2 | 1989 | 7294 | 0.000 |
Why?
|
Esophagitis | 1 | 1979 | 152 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1988 | 1622 | 0.000 |
Why?
|
Intestinal Perforation | 1 | 1979 | 253 | 0.000 |
Why?
|
Risk | 1 | 1989 | 9688 | 0.000 |
Why?
|
Rehabilitation, Vocational | 1 | 1972 | 82 | 0.000 |
Why?
|
Pancreatitis | 1 | 1979 | 1092 | 0.000 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1979 | 1131 | 0.000 |
Why?
|
Serum Globulins | 1 | 1971 | 24 | 0.000 |
Why?
|
Arabinose | 1 | 1970 | 31 | 0.000 |
Why?
|
Histocompatibility Testing | 1 | 1972 | 741 | 0.000 |
Why?
|
ABO Blood-Group System | 1 | 1972 | 367 | 0.000 |
Why?
|
Culture Techniques | 1 | 1970 | 554 | 0.000 |
Why?
|
Azathioprine | 1 | 1971 | 354 | 0.000 |
Why?
|
Dogs | 1 | 1971 | 3912 | 0.000 |
Why?
|
Transplantation, Autologous | 1 | 1971 | 2124 | 0.000 |
Why?
|
Graft Rejection | 1 | 1972 | 4397 | 0.000 |
Why?
|
Brain | 1 | 1986 | 26388 | 0.000 |
Why?
|
Rats | 1 | 1971 | 24252 | 0.000 |
Why?
|